SG11201900127UA - Haemoglobin test kit - Google Patents

Haemoglobin test kit

Info

Publication number
SG11201900127UA
SG11201900127UA SG11201900127UA SG11201900127UA SG11201900127UA SG 11201900127U A SG11201900127U A SG 11201900127UA SG 11201900127U A SG11201900127U A SG 11201900127UA SG 11201900127U A SG11201900127U A SG 11201900127UA SG 11201900127U A SG11201900127U A SG 11201900127UA
Authority
SG
Singapore
Prior art keywords
haemoglobin
international
woodlands
singapore
pct
Prior art date
Application number
SG11201900127UA
Other languages
English (en)
Inventor
Lye Hock Sim
Original Assignee
Cell Id Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Id Pte Ltd filed Critical Cell Id Pte Ltd
Publication of SG11201900127UA publication Critical patent/SG11201900127UA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/726—Devices
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
SG11201900127UA 2016-07-07 2016-07-07 Haemoglobin test kit SG11201900127UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG2016/050314 WO2018009143A1 (en) 2016-07-07 2016-07-07 Haemoglobin test kit

Publications (1)

Publication Number Publication Date
SG11201900127UA true SG11201900127UA (en) 2019-02-27

Family

ID=56418584

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201900127UA SG11201900127UA (en) 2016-07-07 2016-07-07 Haemoglobin test kit

Country Status (7)

Country Link
US (1) US20190302130A1 (de)
EP (1) EP3482212A1 (de)
JP (1) JP2019526057A (de)
CN (1) CN109564228A (de)
PH (1) PH12019500048A1 (de)
SG (1) SG11201900127UA (de)
WO (1) WO2018009143A1 (de)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU602694B2 (en) * 1986-06-09 1990-10-25 Ortho Diagnostic Systems Inc. Improved colloidal gold membrane assay
JP3005303B2 (ja) * 1991-01-31 2000-01-31 湧永製薬株式会社 測定装置
US5843691A (en) * 1993-05-15 1998-12-01 Lifescan, Inc. Visually-readable reagent test strip
US7067264B2 (en) * 2001-07-23 2006-06-27 Bagaria Padma S Test device for detecting human blood and method of use
CA2799996C (en) * 2009-05-20 2018-01-02 Relia Diagnostic Systems, Inc. Systems and methods for determining the percentage of glycated hemoglobin
CN201886026U (zh) * 2010-12-10 2011-06-29 四川迈克生物科技股份有限公司 一种快速定量检测糖化血红蛋白免疫层析试纸条
CN104345149A (zh) * 2013-07-26 2015-02-11 深圳市艾瑞生物科技有限公司 一种检测糖化血红蛋白免疫层析试纸条及其制备方法
JP5735670B1 (ja) * 2014-01-14 2015-06-17 田中貴金属工業株式会社 免疫クロマト分析方法、免疫クロマト分析装置および免疫クロマト分析キット
US20160116489A1 (en) * 2014-10-23 2016-04-28 Biomedomics, Inc. Lateral flow immunoassay method of simultaneously detecting hemoglobin s, hemoglobin c, and hemoglobin a in newborns, infants, children, and adults
CN105527425B (zh) * 2015-12-19 2017-11-14 中国科学院寒区旱区环境与工程研究所 一种百合复合病毒半定量检测金标卡的制备方法

Also Published As

Publication number Publication date
CN109564228A (zh) 2019-04-02
EP3482212A1 (de) 2019-05-15
PH12019500048A1 (en) 2019-10-21
WO2018009143A1 (en) 2018-01-11
US20190302130A1 (en) 2019-10-03
JP2019526057A (ja) 2019-09-12

Similar Documents

Publication Publication Date Title
SG11201909963YA (en) Methods for treating dravet syndrome
SG11201900772YA (en) Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
SG11201811184UA (en) Lag -3 binding members
SG11201903480TA (en) Cell culture device system and methods of use thereof
SG11201804758QA (en) Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab
SG11201408417UA (en) Smoking article for use with an internal heating element
SG11201408489PA (en) Target detection and signal amplification
SG11201408251SA (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
SG11201805906WA (en) Diagnostic and prognostic methods for cardiovascular diseases and events
SG11201408561YA (en) Tunable materials
SG11201407710VA (en) Compositions comprising short-acting benzodiazepines
SG11201408347UA (en) Anti-psma antibodies conjugated to nuclear receptor ligand polypeptides
SG11201407580YA (en) Composition comprising two antibodies engineered to have reduced and increased effector function
SG11201805697WA (en) Multi-stage target cell enrichment using a microfluidic device
SG11201908075UA (en) A microneedle device
SG11201809594WA (en) Nicotine particles and compositions
SG11201406787TA (en) Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies
SG11201808762XA (en) Diagnostic methods for patient specific therapeutic decision making in cancer care
SG11201810916WA (en) IMPROVED SYNTHESIS OF THE RADIOLABELED PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITOR [18F]DCFPyL
SG11201408434QA (en) Targeted rna-seq methods and materials for the diagnosis of prostate cancer
SG11201408333UA (en) Bulk purchasing by ad hoc consumer groups
SG11201807186TA (en) Medical examination gloves
SG11201903602RA (en) Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibody
SG11201808269YA (en) An injection and extraction ophthalmic device
SG11201408083YA (en) Compositions and methods for enhancing mobilization and proliferation of blastomere-like stem cells